EKARNIA
LIVE

Serial Number

79426137

Owner

Limelight Health Ltd

Attorney

Jonathan A. Hyman

Filing Date

Feb 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EKARNIA Trademark

Serial Number: 79426137

EKARNIA is a trademark filed by Limelight Health Ltd on February 6, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Limelight Health Ltd

55 Station Road

Entity Type: 98

Trademark Details

Filing Date

February 6, 2025

Registration Date

Not Registered

Published for Opposition

May 5, 2026

Goods & Services

Hosting of third party content, photos, text, data, images, web sites and other electronic works, namely, hosting of information, including datasheets, fact sheets, leaflets, brochures, supplier information, all relating to suppliers within the pharmaceutical industry; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing suppliers and service providers; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating supplier data for purchasing; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supply chain management; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supplier operational risk management; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing suppliers and service providers; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for generating supplier data for purchasing; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supply chain management; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supplier operational risk management; Platform as a service (PAAS) services featuring software platforms featuring artificial intelligence software for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing suppliers and service providers; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for sourcing goods, managing vendor communications, generating quote comparisons, and managing supply chains and supply chain procurement; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for generating supplier data for purchasing; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supply chain management; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supplier operational risk management; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for supplier identification, supplier fact sheet creation, supply chain analysis and sourcing software for procurement; Software platform services, namely, platform as a service (PaaS) featuring artificial intelligence software for sourcing suppliers and service providers in the pharmaceutical industry through research, analysis and comparison, and making connections with pharmaceutical suppliers; pharmaceutical research and development services; biotech research and development services; consultancy pertaining to pharmacology; providing information relating to scientific research in the fields of biochemistry and biotechnology; preparation of reports in the biotechnology field, namely, biotechnology, scientific and product research information relating to pharmaceutical suppliers and biotechnology research and development information relating to therapy area, location and size; consultancy, advisory and information services relating to the above services

Advertising services; marketing services; market research; provision of business information; data processing services; compilation of business data; business intelligence services; business and commercial information provided by access to a computer database; business performance measurement, assessment, review and monitoring, namely, business management and consultancy services; provision of supplier, vendor, contractor, agency or supply chain information, including sourcing, tender selection and processing requests for information (RFI), namely, providing business and commercial information; provision of performance feedback being business information, performance evaluation, benchmarking reports, and business data analysis about suppliers, vendors, contractors, agencies or businesses in the supply chain; review of suppliers, vendors, contractors or the supply chain through business assessment services, namely, providing independent ratings and reviews of other businesses for commercial purposes; outsourcing services; compilation of business data about suppliers, vendors, contractors and agencies; business consulting services, namely, providing assistance in development of creative ideation; all relating to businesses in the pharmaceutical and biotech industries; consultancy, advisory and information services relating to the above services

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 11, 2026 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 3, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 3, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 3, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 3, 2026 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 17, 2026 GNFN
FINAL REFUSAL E-MAILED
Mar 17, 2026 GNFR
FINAL REFUSAL WRITTEN
Mar 17, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2026 TROA
REFUSAL PROCESSED BY IB
Sep 12, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 26, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 26, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 22, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 21, 2025 CNRT
NEW REPRESENTATIVE AT IB RECEIVED
Jul 18, 2025 NREP
ASSIGNED TO EXAMINER
Jul 16, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 23, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 23, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 19, 2025 REPR